Dr. Rastogi is an Assistant Director of Preclinical Development at Ionis Pharmaceuticals with expertise in mechanistic and developmental toxicology. At Ionis, he drives comprehensive, integrated safety assessments of drug candidates. Prior to joining Ionis, Dr. Rastogi worked at Gradient Corporation, an environmental toxicology consulting firm based in Boston. In this role, he served as a subject matter expert on a variety of projects in the environmental, pharmaceutical, and medical device field. He earned his doctorate in Molecular and Cellular Biology from the University of Massachusetts, Amherst. His research focused on identifying the mechanisms by which endocrine disrupting chemicals exert toxicity in the developing embryo. He has won over 15 awards from the Society of Toxicology, Society for Redox Biology and Medicine and the American Association for the Advancement of the Sciences for his research, including the Carl C Smith Award and the Sheldon D Murphy Award from Mechanisms SS. Dr. Rastogi has been an active SOT member since 2016, and is the current Vice-President Elect of the Mechanisms Specialty Section. He has authored several peer-reviewed research articles and presented his work to diverse scientific and non-scientific audiences, including US legislators.